PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMPH vs. ARCT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AMPHARCT
YTD Return-34.60%-12.94%
1Y Return-30.71%11.45%
3Y Return (Ann)26.12%-5.99%
5Y Return (Ann)14.43%23.07%
Sharpe Ratio-0.660.12
Daily Std Dev42.84%78.81%
Max Drawdown-49.92%-97.70%
Current Drawdown-37.77%-84.63%

Fundamentals


AMPHARCT
Market Cap$1.99B$851.04M
EPS$2.91-$4.03
PE Ratio13.9610.30
Total Revenue (TTM)$676.21M$113.75M
Gross Profit (TTM)$362.00M$64.88M
EBITDA (TTM)$239.32M-$106.49M

Correlation

-0.50.00.51.00.2

The correlation between AMPH and ARCT is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AMPH vs. ARCT - Performance Comparison

In the year-to-date period, AMPH achieves a -34.60% return, which is significantly lower than ARCT's -12.94% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%2024FebruaryMarchAprilMayJune
-33.60%
-13.41%
AMPH
ARCT

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Amphastar Pharmaceuticals, Inc.

Arcturus Therapeutics Holdings Inc.

Risk-Adjusted Performance

AMPH vs. ARCT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AMPH
Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.66, compared to the broader market-2.00-1.000.001.002.003.00-0.66
Sortino ratio
The chart of Sortino ratio for AMPH, currently valued at -0.73, compared to the broader market-4.00-2.000.002.004.00-0.73
Omega ratio
The chart of Omega ratio for AMPH, currently valued at 0.90, compared to the broader market0.501.001.502.000.90
Calmar ratio
The chart of Calmar ratio for AMPH, currently valued at -0.70, compared to the broader market0.002.004.006.00-0.70
Martin ratio
The chart of Martin ratio for AMPH, currently valued at -1.14, compared to the broader market0.0010.0020.00-1.14
ARCT
Sharpe ratio
The chart of Sharpe ratio for ARCT, currently valued at 0.12, compared to the broader market-2.00-1.000.001.002.003.000.12
Sortino ratio
The chart of Sortino ratio for ARCT, currently valued at 0.77, compared to the broader market-4.00-2.000.002.004.000.77
Omega ratio
The chart of Omega ratio for ARCT, currently valued at 1.09, compared to the broader market0.501.001.502.001.09
Calmar ratio
The chart of Calmar ratio for ARCT, currently valued at 0.11, compared to the broader market0.002.004.006.000.11
Martin ratio
The chart of Martin ratio for ARCT, currently valued at 0.37, compared to the broader market0.0010.0020.000.37

AMPH vs. ARCT - Sharpe Ratio Comparison

The current AMPH Sharpe Ratio is -0.66, which is lower than the ARCT Sharpe Ratio of 0.12. The chart below compares the 12-month rolling Sharpe Ratio of AMPH and ARCT.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.002024FebruaryMarchAprilMayJune
-0.66
0.12
AMPH
ARCT

Dividends

AMPH vs. ARCT - Dividend Comparison

Neither AMPH nor ARCT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AMPH vs. ARCT - Drawdown Comparison

The maximum AMPH drawdown since its inception was -49.92%, smaller than the maximum ARCT drawdown of -97.70%. Use the drawdown chart below to compare losses from any high point for AMPH and ARCT. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%2024FebruaryMarchAprilMayJune
-37.77%
-81.95%
AMPH
ARCT

Volatility

AMPH vs. ARCT - Volatility Comparison

The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 6.95%, while Arcturus Therapeutics Holdings Inc. (ARCT) has a volatility of 43.63%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%2024FebruaryMarchAprilMayJune
6.95%
43.63%
AMPH
ARCT

Financials

AMPH vs. ARCT - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items